Minsheng Royal Fund Management Co. - Biotechnology ETF (SHA:516930)
0.5100
0.00 (0.00%)
At close: Sep 22, 2026
SHA:516930 Holdings Information
SHA:516930 is an equity ETF with a total of 52 individual holdings.
Total Holdings
52
Top 10 Percentage
52.59%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
32.00
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SHA: 603259 | WuXi AppTec Co., Ltd. | 11.48% |
| 2 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 10.04% |
| 3 | SHE: 300760 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 8.45% |
| 4 | SHE: 002821 | Asymchem Laboratories (Tianjin) Co., Ltd. | 3.80% |
| 5 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 3.51% |
| 6 | SHA: 688235 | BeOne Medicines AG | 3.49% |
| 7 | SHA: 600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 3.35% |
| 8 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 2.92% |
| 9 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 2.91% |
| 10 | SHA: 688331 | RemeGen Co., Ltd. | 2.65% |
| 11 | SHE: 000661 | Changchun High-Tech Industry (Group) Co., Ltd. | 2.55% |
| 12 | SHA: 688266 | Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 2.54% |
| 13 | SHE: 300142 | Walvax Biotechnology Co., Ltd. | 2.44% |
| 14 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 2.39% |
| 15 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 2.35% |
| 16 | n/a | Cash | 2.34% |
| 17 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 2.13% |
| 18 | SHE: 300122 | Chongqing Zhifei Biological Products Co., Ltd. | 1.64% |
| 19 | SHE: 002007 | Hualan Biological Engineering Inc. | 1.57% |
| 20 | SHA: 688114 | MGI Tech Co., Ltd. | 1.49% |
| 21 | SHA: 688319 | Chengdu Olymvax Biopharmaceuticals Inc. | 1.47% |
| 22 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 1.35% |
| 23 | SHE: 000534 | Wedge Industrial Co.,Ltd. | 1.31% |
| 24 | SHA: 688690 | Suzhou Nanomicro Technology Co., Ltd. | 1.25% |
| 25 | SHE: 300676 | BGI Genomics Co., Ltd. | 1.21% |
As of Jun 30, 2026